New MRT Imaging Biomarkers and Treatment With Kinetic Oscillatory Stimulation (KOS) in Nasal Cavity for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgic Encephalomyelitis, Chronic Fatigue Syndrome
About this trial
This is an interventional treatment trial for Myalgic Encephalomyelitis focused on measuring Myalgic Encephalomyelitis, Chronic Fatigue Syndrome, Kinetic Oscillatory Stimulation in nasal cavity
Eligibility Criteria
Inclusion Criteria:
- Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) established by Consultant in Neurology.
Exclusion Criteria:
- Any cardiovascular disease.
- Any other condition considered by the physician to render the patient unsuitable for participation in the study.
Sites / Locations
- Neurological Rehabilitation Clinic in Stora SköndalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Arm 1, active KOS treatment
Arm 2, 8 inactive KOS treatments then 8 active KOS treatments
Patients in arm 1 receive active KOS treatment throughout study, which means 16 active KOS treatments. Patients receive KOS treatments twice a week during 8 consecutive weeks.
Patients in arm 2 receive inactive KOS treatment during the first 8 KOS treatments of the study. Thereafter patients in arm 2 receive 8 active KOS treatments. Patients receive KOS treatments twice a week during 8 consecutive weeks.